Skip to main content

Advertisement

Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Association between serum S100A9 levels and liver necroinflammation in chronic hepatitis B

Fig. 3

Relationship between serum S100A9 levels and liver necroinflammation or fibrosis. a Distribution of serum S100A9 levels in CHB patients with different phases (no or mild liver necroinflammation, G0–1; moderate-to-severe necroinflammation, G2–4). b Distribution of serum S100A9 levels in CHB patients with different phases of fibrosis (no or mild liver fibrosis, S0–1; moderate-to-severe fibrosis, S2–4). c Distribution of serum S100A9 levels in CHB patients with different degrees of liver damage (no or mild liver damage, G0–1 or S0–1; significant liver damage, G2–4 or S2–4). d Correlation between serum S100A9 levels and ALT levels in CHB patients. e Correlation of serum S100A9 levels with ALT levels in subgroup of HBeAg(−) immune reactivation CHB patients. f Correlation between serum S100A9 levels and ALT levels in subgroup of HBeAg(+) immune-active CHB patients. Data represents the mean ± SD, *p < 0.05; **p < 0.01; ***p < 0.001

Back to article page